Chief Executive OfficerVarmX, Leiden, The NetherlandsLeiden, Zuid-Holland, Netherlands
OC 43.1 - A novel bleeding model in monkeys to assess efficacy of VMX-C001 for bypassing of FXa-DOAC anticoagulation
Monday, June 24, 202414:45 – 15:00 ICT